148 related articles for article (PubMed ID: 34997917)
21. Call for Action: Benzodiazepine Prescription Prevalence Analysis Shows Off-Label Prescription in One in Eleven Citizens.
López-Pelayo H; Coma A; Gual A; Zara C; Lligoña A
Eur Addict Res; 2019; 25(6):320-329. PubMed ID: 31494655
[TBL] [Abstract][Full Text] [Related]
22. PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study).
Di Salvo M; Santi Laurini G; Motola D; Valpiani G; Sapigni E; Pompilio A; Arzenton E; Marra A
Br J Clin Pharmacol; 2024 Apr; 90(4):1050-1057. PubMed ID: 38163762
[TBL] [Abstract][Full Text] [Related]
23. Off-label use of proton pump inhibitors and P-blockers in general practices: an analysis using the Disease Analyzer--mediplus patient database.
Schröder-Bernhardi D; Roth K; Dietlein G
Int J Clin Pharmacol Ther; 2004 Nov; 42(11):581-8. PubMed ID: 15598023
[TBL] [Abstract][Full Text] [Related]
24. Off-label use of prescription drugs in childhood and adolescence: an analysis of prescription patterns in Germany.
Mühlbauer B; Janhsen K; Pichler J; Schoettler P
Dtsch Arztebl Int; 2009 Jan; 106(3):25-31. PubMed ID: 19564959
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Awareness and Experience of Using off-label Drugs by Doctors of Clinical Specialties.
Drapkina OM; Shepel RN; Martsevich SY; Kutishenko NP; Berns SA; Bulgakova ES; Orlov DO; Belkin IA
Kardiologiia; 2021 May; 61(5):41-50. PubMed ID: 34112074
[TBL] [Abstract][Full Text] [Related]
26. Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology.
Schrier L; Hadjipanayis A; Stiris T; Ross-Russell RI; Valiulis A; Turner MA; Zhao W; De Cock P; de Wildt SN; Allegaert K; van den Anker J
Eur J Pediatr; 2020 May; 179(5):839-847. PubMed ID: 31897842
[TBL] [Abstract][Full Text] [Related]
27. Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center.
Cenna R; Basiricò M; Berchialla P; Bertorello N; Cagnazzo C; Ceolin V; De Luna E; Nolis C; Resente F; Fagioli F
Pediatr Blood Cancer; 2023 Mar; 70(3):e30148. PubMed ID: 36583462
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Off-label and Unlicensed Medicines in Children.
Lee JH; Byon HJ; Choi S; Jang YE; Kim EH; Kim JT; Kim HS
J Korean Med Sci; 2018 Sep; 33(37):e227. PubMed ID: 30190655
[TBL] [Abstract][Full Text] [Related]
29. Current practice and awareness of pediatric off-label drug use in Shanghai, China -a questionnaire-based study.
Mei M; Xu H; Wang L; Huang G; Gui Y; Zhang X
BMC Pediatr; 2019 Aug; 19(1):281. PubMed ID: 31409339
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA.
Zhu X; Hu J; Sun B; Deng S; Wen Y; Chen W; Qiu C; Shang D; Zhang M
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):216-224. PubMed ID: 29336603
[TBL] [Abstract][Full Text] [Related]
31. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
32. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
Dos Santos L; Heineck I
Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
[TBL] [Abstract][Full Text] [Related]
33. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
34. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
35. New prescriptions of spironolactone associated with angiotensin-converting-enzyme inhibitors and/or angiotensin receptor blockers and their laboratory monitoring from 2001 to 2008: a population study on older people living in the community in Italy.
Bilotta C; Franchi C; Nobili A; Nicolini P; Djade CD; Tettamanti M; Fortino I; Bortolotti A; Merlino L; Vergani C
Eur J Clin Pharmacol; 2013 Apr; 69(4):909-17. PubMed ID: 22996075
[TBL] [Abstract][Full Text] [Related]
36. Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study.
Viola E; Trifirò G; Ingrasciotta Y; Sottosanti L; Tari M; Giorgianni F; Moretti U; Leone R
Expert Opin Drug Saf; 2016 Dec; 15(sup2):61-67. PubMed ID: 27875919
[TBL] [Abstract][Full Text] [Related]
37. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
38. Off-label drug prescribing in a Portuguese paediatric emergency unit.
Ribeiro M; Jorge A; Macedo AF
Int J Clin Pharm; 2013 Feb; 35(1):30-6. PubMed ID: 23054136
[TBL] [Abstract][Full Text] [Related]
39. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
Lee JL; Redzuan AM; Shah NM
Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
[TBL] [Abstract][Full Text] [Related]
40. Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease.
Pasquali SK; Hall M; Slonim AD; Jenkins KJ; Marino BS; Cohen MS; Shah SS
Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):74-83. PubMed ID: 20031793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
